{"id":"W4242192132","doi":"10.1200/jco.2020.38.15_suppl.11518","title":"A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Clinical endpoint; Oncology; Response Evaluation Criteria in Solid Tumors; Progressive disease; Progression-free survival; Immune checkpoint; Phases of clinical research; Interim analysis; Cancer; Immunotherapy; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00248034,0.002189726,0.002943367,0.0007098584,0.000603529,0.001494575,0.001311443,0.001833461,0.004431005],"category_scores_gemma":[0.001249534,0.00098595,0.001335961,0.0005278894,0.001526071,0.001579787,0.0004784701,0.00394742,0.001593584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00149626,"about_ca_system_score_gemma":0.002185233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001243819,"about_ca_topic_score_gemma":0.002696038,"domain_scores_codex":[0.9993263,0.0002540214,0.00003160436,0.0001308045,0.00005949123,0.0001978464],"domain_scores_gemma":[0.9988098,0.0001331719,0.0001624864,0.0001198653,0.00005849209,0.0007161698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.803708,0.1275802,0.004470885,0.0004432777,0.0008357422,0.0001898499,0.0002614928,0.001742292,0.02059353,0.0002656472,0.001787941,0.03812118],"study_design_scores_gemma":[0.4983907,0.4907813,0.006341159,0.00001817321,0.0002303572,0.000134137,0.00006295977,0.0008613754,0.001455826,0.0002147535,0.001481904,0.00002722878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891627,0.001011729,0.0006168449,0.0003389294,0.0002363681,0.00589756,0.0008902565,0.00009717154,0.001748371],"genre_scores_gemma":[0.9832473,0.0008615633,0.001972907,0.00105287,0.0002641423,0.007597199,0.001637065,0.00003745934,0.003329405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004431005,"threshold_uncertainty_score":0.0148232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1279654672942123,"score_gpt":0.4439812238453233,"score_spread":0.316015756551111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}